Tingting Zhang
Key Laboratory Of Cancer Prevention And Therapy, Huanhuxi Road, Tiyuanbei
Dayingmen, 300060, China
Dayingmen, 300060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Correction to: Risk factors for POD24 in patients with previously untreated follicular lymphoma: a systematic review and meta‑analysis.
Journal: Annals of hematology
Published: October 18, 2022
m6A-Regulator Expression Signatures Identify a Subset of Follicular Lymphoma Harboring an Exhausted Tumor Microenvironment.
Journal: Frontiers in immunology
Published: April 18, 2022
Genetic characteristics involving the PD-1/PD-L1/L2 and CD73/A2aR axes and the immunosuppressive microenvironment in DLBCL.
Journal: Journal for immunotherapy of cancer
Published: March 14, 2022
Screening of Adverse Prognostic Factors and Construction of Prognostic Index in Previously Untreated Concurrent Follicular Lymphoma and Diffuse Large B-Cell Lymphoma.
Journal: BioMed research international
Published: March 04, 2022
A novel immune-related epigenetic signature based on the transcriptome for predicting the prognosis and therapeutic response of patients with diffuse large B-cell lymphoma.
Journal: Clinical immunology (Orlando, Fla.)
Published: February 24, 2022
Clinical features and outcomes of patients with follicular lymphoma: A real-world study of 926 patients in China.
Journal: Frontiers in oncology
Published: January 26, 2022
PIM1 genetic alterations associated with distinct molecular profiles, phenotypes and drug responses in diffuse large B-cell lymphoma.
Journal: Clinical and translational medicine
Published: December 21, 2021
Tracking the evolution of untreated high-intermediate/high-risk diffuse large B-cell lymphoma by circulating tumour DNA.
Journal: British journal of haematology
Published: July 11, 2021
Comprehensive analysis of TP53 mutation characteristics and identification of patients with inferior prognosis and enhanced immune escape in diffuse large B-cell lymphoma.
Journal: American journal of hematology
Published: June 26, 2021
An Immune-Clinical Prognostic Index (ICPI) for Patients With De Novo Follicular Lymphoma Treated With R-CHOP/CHOP Chemotherapy.
Journal: Frontiers in oncology
Published: May 12, 2021
Corrigendum to "Genetic Mutations of Tim-3 Ligand and Exhausted Tim-3+ CD8+ T Cells and Survival in Diffuse Large B Cell Lymphoma".
Journal: Journal of immunology research
Published: January 21, 2021
Last Updated: 09/26/2026